Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October)
Full Issue
Requires Subscription
pdf
Commentary
Original article
-
When the available blood supply mismatches the needs of the patient: Mismatches between blood supply and patient needs
-
Red blood cell alloantibodies in the context of critical bleeding and massive transfusion: Red cell alloantibodies in critical bleeding massive transfusion
-
Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPTtm Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience: Efficiency of pathogen-reduced platelet transfusion
-
Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage: Lipidomic of transfusion-dedicated platelet concentrate
-
Dissecting the complexity of pediatric blood transfusions and risk of adverse reactions in Aotearoa New Zealand: Pediatric transfusions and adverse reaction risk in NZ
-
Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features: Autoimmunity and steroids in MDS